Adi Wilf‐Yarkoni

919 total citations
24 papers, 496 citations indexed

About

Adi Wilf‐Yarkoni is a scholar working on Neurology, Pathology and Forensic Medicine and Ophthalmology. According to data from OpenAlex, Adi Wilf‐Yarkoni has authored 24 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Pathology and Forensic Medicine and 5 papers in Ophthalmology. Recurrent topics in Adi Wilf‐Yarkoni's work include Peripheral Neuropathies and Disorders (7 papers), Multiple Sclerosis Research Studies (7 papers) and Retinal and Optic Conditions (5 papers). Adi Wilf‐Yarkoni is often cited by papers focused on Peripheral Neuropathies and Disorders (7 papers), Multiple Sclerosis Research Studies (7 papers) and Retinal and Optic Conditions (5 papers). Adi Wilf‐Yarkoni collaborates with scholars based in Israel, Germany and United States. Adi Wilf‐Yarkoni's co-authors include Roman Gersner, Abraham Zangen, Dalit E. Dar, Mark A. Hellmann, Gal Richter‐Levin, Erika Tóth, Itay Lotan, Israel Steiner, Michal Schwartz and Yaniv Ziv and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biological Psychiatry.

In The Last Decade

Adi Wilf‐Yarkoni

22 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adi Wilf‐Yarkoni Israel 11 163 131 117 97 70 24 496
Moogeh Baharnoori Canada 11 81 0.5× 39 0.3× 117 1.0× 78 0.8× 117 1.7× 28 490
Nicole Katchur United States 5 55 0.3× 171 1.3× 38 0.3× 98 1.0× 35 0.5× 9 519
Elaine O’Loughlin United States 8 58 0.4× 44 0.3× 89 0.8× 59 0.6× 37 0.5× 10 471
Maude Bordeleau Canada 16 79 0.5× 162 1.2× 139 1.2× 71 0.7× 46 0.7× 19 741
Andrea Francesca Salvador United States 7 87 0.5× 49 0.4× 172 1.5× 111 1.1× 26 0.4× 8 661
Pamela Esposito United States 8 136 0.8× 29 0.2× 97 0.8× 73 0.8× 49 0.7× 8 640
Tamar Koren Israel 5 62 0.4× 36 0.3× 112 1.0× 71 0.7× 27 0.4× 8 654
Kimon Runge Germany 16 49 0.3× 259 2.0× 171 1.5× 69 0.7× 8 0.1× 55 708
Nadia Boshnak Israel 5 62 0.4× 34 0.3× 111 0.9× 66 0.7× 27 0.4× 5 644
Stefan Busse Germany 16 128 0.8× 87 0.7× 326 2.8× 95 1.0× 41 0.6× 37 755

Countries citing papers authored by Adi Wilf‐Yarkoni

Since Specialization
Citations

This map shows the geographic impact of Adi Wilf‐Yarkoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Wilf‐Yarkoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Wilf‐Yarkoni more than expected).

Fields of papers citing papers by Adi Wilf‐Yarkoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi Wilf‐Yarkoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Wilf‐Yarkoni. The network helps show where Adi Wilf‐Yarkoni may publish in the future.

Co-authorship network of co-authors of Adi Wilf‐Yarkoni

This figure shows the co-authorship network connecting the top 25 collaborators of Adi Wilf‐Yarkoni. A scholar is included among the top collaborators of Adi Wilf‐Yarkoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi Wilf‐Yarkoni. Adi Wilf‐Yarkoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilf‐Yarkoni, Adi, et al.. (2024). Clinical Characterization and Ancillary Tests in Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200209–e200209. 5 indexed citations
2.
Ganelin‐Cohen, Esther, Adi Vaknin‐Dembinsky, Mark A. Hellmann, et al.. (2024). The effect of COVID‐19 vaccination on multiple sclerosis activity as reflected by MRI. Brain and Behavior. 14(7). e3587–e3587.
3.
Hellmann, Mark A., et al.. (2024). Association between clinical characteristics, acute steroid treatment and oligoclonal bands result in multiple sclerosis: A retrospective study. Multiple Sclerosis and Related Disorders. 85. 105554–105554. 1 indexed citations
4.
Fuchs, Lior, Adi Wilf‐Yarkoni, Hadar Kolb, et al.. (2024). Clinical Characterization and Prognostic Risk Factors of Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200357–e200357. 1 indexed citations
5.
Wilf‐Yarkoni, Adi, et al.. (2023). Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysis. Epilepsia. 64(9). 2322–2329. 10 indexed citations
6.
Petrou, Panayiota, Anat Achiron, David Magalashvili, et al.. (2023). Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint. Journal of Neurology. 270(11). 5188–5195. 3 indexed citations
7.
Wilf‐Yarkoni, Adi, Kerstin Rubarth, Rebekka Rust, et al.. (2023). Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis. PLoS ONE. 18(12). e0288366–e0288366. 1 indexed citations
8.
Stiebel‐Kalish, Hadas, Kerstin Rubarth, Itay Lotan, et al.. (2022). Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Scientific Reports. 12(1). 21312–21312. 6 indexed citations
9.
Lotan, Itay, et al.. (2022). Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis. Neuromuscular Disorders. 32(3). 230–235. 11 indexed citations
10.
Wilf‐Yarkoni, Adi, et al.. (2022). Repeated lumbar puncture in search of oligoclonal bands – What is the yield?. Journal of the Neurological Sciences. 439. 120298–120298. 4 indexed citations
11.
Zur, Dinah, Michaella Goldstein, Yahav Oron, et al.. (2021). Susac’s syndrome – A new ocular finding and disease outcome. Eye. 36(4). 781–788. 4 indexed citations
12.
Wilf‐Yarkoni, Adi, Itay Lotan, Israel Steiner, & Mark A. Hellmann. (2021). Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis. Journal of Neurology. 268(10). 3871–3877. 8 indexed citations
13.
Lotan, Itay, et al.. (2021). Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel. European Journal of Neurology. 28(11). 3742–3748. 41 indexed citations
14.
Lotan, Itay, Mark A. Hellmann, Adi Wilf‐Yarkoni, & Israel Steiner. (2020). Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review. Journal of Neurology. 268(12). 4573–4586. 29 indexed citations
15.
Wilf‐Yarkoni, Adi, Ori Elkayam, Orna Aizenstein, et al.. (2020). Increased incidence of Susac syndrome: a case series study. BMC Neurology. 20(1). 332–332. 22 indexed citations
16.
Golan, Maya, Karin Mausner-Fainberg, Adi Wilf‐Yarkoni, et al.. (2019). Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis. CNS Drugs. 33(12). 1229–1237. 11 indexed citations
17.
Mausner-Fainberg, Karin, et al.. (2019). Reduced levels of Coco in sera of multiple sclerosis patients: A potential role in neuro-regeneration failure. Journal of Neuroimmunology. 327. 36–40. 3 indexed citations
18.
Herman, Talia, Aner Weiss, Marina Brozgol, et al.. (2014). Cognitive function and other non-motor features in non-demented Parkinson’s disease motor subtypes. Journal of Neural Transmission. 122(8). 1115–1124. 39 indexed citations
19.
Lewitus, Gil M., Adi Wilf‐Yarkoni, Yaniv Ziv, et al.. (2008). Vaccination as a Novel Approach for Treating Depressive Behavior. Biological Psychiatry. 65(4). 283–288. 93 indexed citations
20.
Tóth, Erika, Roman Gersner, Adi Wilf‐Yarkoni, et al.. (2008). Age‐dependent effects of chronic stress on brain plasticity and depressive behavior. Journal of Neurochemistry. 107(2). 522–532. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moogeh Baharnoori Breakdown of academic impact, for papers by Nicole Katchur Breakdown of academic impact, for papers by Elaine O’Loughlin Breakdown of academic impact, for papers by Maude Bordeleau Breakdown of academic impact, for papers by Andrea Francesca Salvador Breakdown of academic impact, for papers by Pamela Esposito Breakdown of academic impact, for papers by Tamar Koren Breakdown of academic impact, for papers by Kimon Runge Breakdown of academic impact, for papers by Nadia Boshnak Breakdown of academic impact, for papers by Stefan Busse
Rankless by CCL
2026